Compound Formulation Library

Frequently Asked Questions

Are compounded medications FDA-approved?

Compounded preparations are prepared by licensed pharmacists to fulfill individual patient prescriptions. They are not FDA-approved products and have not been evaluated by the FDA for safety or efficacy for any specific indication. Clinical decisions about when a compounded preparation is appropriate are made by the treating clinician.

How do I request a compounded medication that isn't listed?

To request a compounded medication that is not listed on our website, submit a custom preparation request with the desired ingredient(s), strength, and dosage form. Click here to submit a request

What states are you licensed in?

To see which states Valor is currently licensed in, visit our States We Serve page.

Do you compound GLP-1 medications like semaglutide or tirzepatide?

No. Valor does not compound semaglutide, tirzepatide, or any other GLP-1 receptor agonists. Semaglutide and tirzepatide are commercially available FDA-approved medications, and federal law does not permit 503A compounding pharmacies to compound these preparations.

Do you compound peptide therapies?

Peptide therapies are not currently available through Valor Compounding Pharmacy because federal regulations limit the substances that 503A compounding pharmacies may use. We actively monitor FDA guidance and ongoing regulatory discussions regarding peptide compounding and will continue to assess any future changes that may affect availability.

Do you compound nutraceuticals or dietary supplements?

We not compound nutraceuticals or dietary supplements because these products are regulated as dietary supplements rather than prescription drugs. The ingredients used in dietary supplements do not meet the pharmaceutical standards required for compounded prescriptions, and California pharmacy regulations do not permit their compounding into prescription preparations.

Questions? We're here to help.

Give us a call or send an email by clicking the buttons below.